3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
63
Carcinoma, Intraductal, Noninfiltrating
8
Breast Carcinoma In Situ
6
Neoplasms
4
Breast Neoplasms, Male
3
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Infertility
2
Endometrial Neoplasms
2
Breast Diseases
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rhabdoid Tumor
1
Pyloric Stenosis, Hypertrophic
1
Precancerous Conditions
1
Polycystic Ovary Syndrome
1
Pinealoma
1
Pancreatic Neoplasms
1
Pancreatic Cyst
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Neoplasms by Site
1
Neoplasm Metastasis
1
Multiple Endocrine Neoplasia Type 1
1
Medulloblastoma
1
Inflammatory Breast Neoplasms
1
Hypogonadism
1
Hyperglycemia
1
Hot Flashes
1
Interventions
Metformin
21
Inositol
13
Letrozole
9
Exercise
5
Surveys and Questionnaires
4
Clomiphene
4
Tablets
3
Estradiol
3
semaglutide
2
maltodextrin
2
drospirenone and ethinyl estradiol combination
2
Spironolactone
2
Progesterone
2
Ethinyl Estradiol
2
Diet Therapy
2
Contraceptives, Oral, Combined
2
Caloric Restriction
2
Acupuncture Therapy
2
salicylsalicylic acid
1
mirabegron
1
etonogestrel
1
drospirenone
1
dapagliflozin
1
cetrorelix
1
Walking
1
Tirzepatide
1
Thyroxine
1
Thioctic Acid
1
Tamoxifen
1
Sodium-Glucose Transporter 2 Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Polycystic Ovary Syndrome
×
Tamoxifen
×
1 year
×
Clear all
NCT07616973
2026-06-01
LET-CC-TAM
Sana'a University
Phase 3
Active not recruiting
240 enrolled